Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors
08 nov. 2021 09h15 HE
|
Adhera Therapeutics, Inc.
Baton Rouge, LA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce the...